Growth Metrics

Apellis Pharmaceuticals (APLS) Other Working Capital Changes (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Other Working Capital Changes readings, the most recent being -$5.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 68.69% year-over-year to -$5.1 million, compared with a TTM value of $8.1 million through Dec 2025, up 125.91%, and an annual FY2025 reading of $8.1 million, up 125.91% over the prior year.
  • Other Working Capital Changes hit -$5.1 million in Q4 2025 for Apellis Pharmaceuticals, down from $2.4 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $35.1 million in Q4 2021, with the low at -$16.2 million in Q4 2024.
  • Median Other Working Capital Changes over the past 5 years was $657500.0 (2022), compared with a mean of $845400.0.
  • The sharpest move saw Other Working Capital Changes skyrocketed 15021.7% in 2021, then crashed 242.31% in 2022.
  • Year by year, Other Working Capital Changes stood at $35.1 million in 2021, then crashed by 82.93% to $6.0 million in 2022, then plummeted by 206.76% to -$6.4 million in 2023, then crashed by 153.3% to -$16.2 million in 2024, then soared by 68.69% to -$5.1 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$5.1 million, $2.4 million, and -$8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.